Biochemical and Molecular Characterization of Marstacimab and TFPI Pathways
Convoca: Pfizer, Inc
Termini: 01/07/2026
Biochemical and Molecular Characterization of Marstacimab and TFPI Pathways
on 18 de maig de 2026
with No hi ha comentaris

Deixa un comentari